BioAge Labs Inc. (BIOA) vs Niagen Bioscience Inc (NAGE)

A side-by-side comparison of BioAge Labs Inc. and Niagen Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BIOA vs NAGE

growth of $100 · dividends reinvested · last 2y
BIOA -65.3% (-41.1%/yr)NAGE -29.1% (-15.8%/yr)NAGE compounded faster over this window
0100200300400Start $10020252026$35$71
BIOA NAGE

BIOA vs NAGE: by the numbers

  • •BIOA is the larger company ($234M vs $215M market cap).
  • •NAGE is profitable (12.39% net margin) while BIOA runs a net loss (-912.25%).

Metrics side by side

Valuation

MetricBIOANAGE
P/E ratioN/A14.45
Forward P/EN/A18.68
P/S ratio22.621.66
P/B ratio0.622.60
EV / EBITDAN/A14.38
FCF yieldN/A2.65%

Profitability

MetricBIOANAGE
Gross margin99.39%64.24%
Operating margin-1026.28%6.67%
Net margin-912.25%12.39%
ROE-25.20%19.38%
ROIC-28.14%8.84%

Growth (annualized)

MetricBIOANAGE
Revenue CAGR (5Y)N/A15.80%
Total return CAGR (5Y)N/A-15.72%

Frequently asked

Is BIOA or NAGE more profitable?
NAGE runs the higher net margin — BIOA at -912.25% versus NAGE at 12.39%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.